PMC:7161517 / 14511-14761
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T83 | 64-68 | Body_part | denotes | gene | http://purl.org/sig/ont/fma/fma74402 |
| T84 | 73-80 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
| T85 | 119-133 | Body_part | denotes | arterial blood | http://purl.org/sig/ont/fma/fma83066 |
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T45 | 119-133 | Body_part | denotes | arterial blood | http://purl.obolibrary.org/obo/UBERON_0013755 |
| T46 | 128-133 | Body_part | denotes | blood | http://purl.obolibrary.org/obo/UBERON_0000178 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T141 | 64-68 | http://purl.obolibrary.org/obo/OGG_0000000002 | denotes | gene |
| T142 | 119-127 | http://purl.obolibrary.org/obo/UBERON_0001637 | denotes | arterial |
| T143 | 119-127 | http://www.ebi.ac.uk/efo/EFO_0000814 | denotes | arterial |
| T144 | 128-133 | http://purl.obolibrary.org/obo/UBERON_0000178 | denotes | blood |
| T145 | 128-133 | http://www.ebi.ac.uk/efo/EFO_0000296 | denotes | blood |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T195 | 36-46 | Chemical | denotes | olmesartan | http://purl.obolibrary.org/obo/CHEBI_48416 |
| T196 | 73-80 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
| T197 | 221-229 | Chemical | denotes | atenolol | http://purl.obolibrary.org/obo/CHEBI_2904|http://purl.obolibrary.org/obo/CHEBI_55352 |
| T199 | 233-244 | Chemical | denotes | hydralazine | http://purl.obolibrary.org/obo/CHEBI_5775 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T97 | 0-250 | Sentence | denotes | The possibility that the effects of olmesartan on vascular ACE2 gene and protein expression were the result of reduced arterial blood pressure was ruled out because of the comparative effect observed in mice treated with atenolol or hydralazine (44). |
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T549 | 59-63 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
| T550 | 64-68 | SO:0000704;GO:0010467 | denotes | gene |
| T551 | 73-80 | BV_20 | denotes | protein |
| T552 | 81-91 | BV_20;GO:0010467 | denotes | expression |
| T553 | 119-133 | UBERON:0013755 | denotes | arterial blood |
| T554 | 203-207 | NCBITaxon:10088 | denotes | mice |
| T555 | 221-229 | CHEBI:2904;CHEBI:2904 | denotes | atenolol |
| T556 | 233-244 | CHEBI:5775;CHEBI:5775 | denotes | hydralazine |
| T22953 | 21-31 | GO:0010467 | denotes | the effect |
| T33050 | 39-42 | PR:000001251 | denotes | esa |
| T74336 | 68-79 | CHEBI:9434;CHEBI:9434 | denotes | and protei |
| T29878 | 95-103 | GO:0016020 | denotes | e the re |
| T86770 | 104-108 | PR:000001307 | denotes | ult |
| T46947 | 109-119 | GO:0010467 | denotes | f reduced |
| T78149 | 132-160 | PR:000000046 | denotes | d pressure was ruled out bec |
| T7543 | 170-180 | GO:0010467 | denotes | e comparat |
| T19226 | 211-215 | NCBITaxon:10114 | denotes | ated |
| T6758 | 226-241 | UBERON:0001621 | denotes | lol or hydralaz |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 620 | 59-63 | Gene | denotes | ACE2 | Gene:70008 |
| 623 | 203-207 | Species | denotes | mice | Tax:10090 |
| 630 | 36-46 | Chemical | denotes | olmesartan | MESH:C437965 |
| 631 | 221-229 | Chemical | denotes | atenolol | MESH:D001262 |
| 632 | 233-244 | Chemical | denotes | hydralazine | MESH:D006830 |
2_test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 32305401-15833808-55252954 | 246-248 | 15833808 | denotes | 44 |